Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05345457

Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
88 (estimated)
Sponsor
University Hospitals Cleveland Medical Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

A randomized, controlled, non-placebo trial to primarily assess the effect of oral, outpatient antibiotics (i.e., azithromycin and amoxicillin) on latency (i.e., proportion of patients that deliver within 28 days from membrane rupture) following previable, prelabor rupture of membranes between 18 0/7 and 22 6/7 weeks gestational age.

Conditions

Interventions

TypeNameDescription
DRUGAzithromycin PillAzithromycin will be dosed as single 500 mg dose (2-250mg oral tablets) administered immediately following randomization, yet prior to discharge to home, followed with 1-250mg oral tablet daily for 4 additional days (for a total of 5 days).
DRUGAmoxicillin PillAmoxicillin will be dosed as a single-500mg oral tablet three times daily for 7 days with first dose also being given prior to discharge home.

Timeline

Start date
2023-01-13
Primary completion
2026-06-01
Completion
2027-06-01
First posted
2022-04-26
Last updated
2025-04-22

Locations

3 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05345457. Inclusion in this directory is not an endorsement.